OptiNose (OPTN) Competitors

Mustang Bio (NASDAQ:MBIO) and OptiNose (NASDAQ:OPTN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Is MBIO or OPTN more profitable?

Mustang Bio has a net margin of 0.00% compared to OptiNose's net margin of -41.16%. OptiNose's return on equity of 0.00% beat Mustang Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mustang Bio	N/A	-1,243.22%	-172.89%
OptiNose	-41.16%	N/A	-27.42%

Which has more volatility & risk, MBIO or OPTN?

Mustang Bio has a beta of 1.92, meaning that its stock price is 92% more volatile than the S&P 500. Comparatively, OptiNose has a beta of -0.07, meaning that its stock price is 107% less volatile than the S&P 500.

Do insiders and institutionals have more ownership in MBIO or OPTN?

10.0% of Mustang Bio shares are owned by institutional investors. Comparatively, 85.6% of OptiNose shares are owned by institutional investors. 0.8% of Mustang Bio shares are owned by insiders. Comparatively, 2.7% of OptiNose shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the media favor MBIO or OPTN?

In the previous week, OptiNose had 4 more articles in the media than Mustang Bio. MarketBeat recorded 7 mentions for OptiNose and 3 mentions for Mustang Bio. OptiNose's average media sentiment score of 0.46 beat Mustang Bio's score of -0.21 indicating that OptiNose is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mustang Bio	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
OptiNose	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has higher valuation & earnings, MBIO or OPTN?

OptiNose has higher revenue and earnings than Mustang Bio. OptiNose is trading at a lower price-to-earnings ratio than Mustang Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mustang Bio	N/A	N/A	-$51.60M	-$1.56	-0.13
OptiNose	$70.99M	0.78	-$35.48M	-$0.28	-1.31

Do analysts recommend MBIO or OPTN?

Mustang Bio currently has a consensus target price of $2.00, indicating a potential upside of 856.94%. OptiNose has a consensus target price of $3.00, indicating a potential upside of 717.44%. Given Mustang Bio's higher possible upside, research analysts plainly believe Mustang Bio is more favorable than OptiNose.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mustang Bio	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
OptiNose	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community favor MBIO or OPTN?

OptiNose received 78 more outperform votes than Mustang Bio when rated by MarketBeat users. However, 64.26% of users gave Mustang Bio an outperform vote while only 63.50% of users gave OptiNose an outperform vote.

Company	Underperform	Outperform
Mustang Bio	Outperform Votes 169 64.26%	Underperform Votes 94 35.74%
OptiNose	Outperform Votes 247 63.50%	Underperform Votes 142 36.50%

Summary

OptiNose beats Mustang Bio on 11 of the 16 factors compared between the two stocks.